Skip to main content

Four sectors, 20 stocks that look attractive after June quarter earnings

Even management commentary gave the market a confident outlook to withstand businesses against the COVID spread and its impact.

Prashanth Tapse

Looking beyond and after June quarter earnings, investors are now flocking to virus-resilient sectors in the market. And despite COVID-19 severely hampering economic activity, markets consistently surged on better-than-expected June quarter earnings and on hopes of COVID-19 vaccine. Indian investor sentiment was also boosted by domestic liquidity, which continued to drive Indian equities in tandem with global markets.

Even management commentary gave the market a confident outlook to withstand businesses against the COVID spread and its impact. With unlocking formulas supporting phased re-opening of economic activity, market started discounting the severity of impact of virus spread over businesses, going forward. But it seems like more businesses are dealing with coronavirus and markets have learnt to live with it.

Here are sectors which we believe investors should focus on and invest in after June quarter earnings session:

Life Insurance a sweet spot sector: Life Insurance Corporation (LIC) clocked a sharp 40 percent month-on-month growth in individual premiums in July and August, led by a jump in the sales of big-ticket pension and term assurance plans. We believe life insurance space in India has been gaining significant traction, with top private sector players delivering strong performances over the past two to three years. We expect private insurance companies like HDFC Life, SBI Life and ICICI Prudential Life could see the same traction in premium collection growth.

Defence sector stocks to be in action on the back of Atma Nirbhar Bharat boost: The procurements will focus on indigenous design and development. Platforms and equipment worth Rs 31,130 crore will be procured from Indian companies and they will be manufactured in India. In the last 5 years, India has spent Rs 3.5 trillion on import of defence items and expects the opportunities of Rs 4 trillion in next 5 years, hence defence stocks like Bharat Dynamics, Bharat Electronics, ZenTech, Cochin Shipyard, HAL and L&T are set to benefit.


The real estate sector can see a boost in the coming quarter: The Centre makes a countrywide effort to push affordable housing and Maharashtra is considering reducing stamp duty on real estate from 5 percent to 2-3 percent in order to give a boost to the industry. The government recently appointed a committee, under the chairmanship of HDFC head Deepak Parekh, to make recommendations to boost the sector. One of its recommendations was to cut stamp duty by 50 percent. Realty & building material stocks to be focused in coming quarters. We like Kolte-Patil, Godrej Properties, Sobha, Brigade Enterprises, Raymond, Ashiana Housing etc. Paints /Tiles stocks are also to follow the trend.

Government's move to build a better infrastructure sector: National Infrastructure Pipeline will ease COVID hit on the economy. Government has identified about 7,000 projects in different sectors that will be part of the National Infrastructure Pipeline. The National Infrastructure Pipeline will play a crucial role in resurrecting the country's economy from the impact of the corona outbreak and the country is going to spend more than Rs 100 lakh crore on this. Hence we are bullish on stocks such as Larsen & Toubro, Ashoka buildcon, Dilip Buildcon, KEC International and KNR Construction.

The author is AVP Research at Mehta Equities.

Disclaimer: The views and investment tips expressed by investment expert on Moneycontrol.com are his own and not that of the website or its management. Moneycontrol.com/SD Solutions advises users to check with certified experts before taking any investment decisions.

Source - Moneycontrol.com

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more